MET and hepatocellular carcinoma: Therefore, we investigated the possible tumor-suppressing functions of Brg1 in mice and found that deletion of Brg1 cooperates with activated Ras/MAPK signaling (via either c-MET or NRASV12 overexpression) to promote HCC development in mice.